Viewing nowLobatan Tablet 5 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Kips Biopharma Co., Ltd.

MFDS item code 201403881 · Approved 2014.08.20 · Insurance code 693201010
Treatment of dyslipidemia, reduction of cardiovascular disease risk, and inhibition of atherosclerosis progression
This medication is primarily used as a treatment for patients with hypercholesterolemia and hyperlipidemia. It helps as an adjunct to diet in patients with primary hypercholesterolemia, especially those with familial hypercholesterolemia who are not controlled by diet and exercise. It is also used in conjunction with diet or other lipid-lowering therapies for the treatment of patients with homozygous familial hypercholesterolemia. This drug lowers total cholesterol and LDL cholesterol and has the effect of slowing the progression of atherosclerosis. It is also used as an adjunct to diet to reduce blood cholesterol levels in children aged 10 to 17 years with heterozygous familial hypercholesterolemia. Moreover, it helps reduce the risk of complications such as stroke, myocardial infarction, and revascularization procedures in high-risk cardiovascular patients with elevated high-sensitivity C-reactive protein levels. In summary, this drug is used to improve various forms of dyslipidemia associated with hypercholesterolemia and reduce the risk of cardiovascular disease.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), combined hyperlipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, and most patients are controlled at this dose. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer based on LDL cholesterol levels, treatment goals, and the patient's response; it may be increased to a maximum of 20 milligrams daily. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Age 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years: Safety and efficacy have not been established.
This medication should not be administered to certain patients. For instance, it should not be used in individuals who are allergic to any of its components, have severely impaired liver function, have muscle disorders, have significantly reduced kidney function, or are pregnant or breastfeeding. Additionally, high doses of this medication are prohibited in patients who are prone to muscle problems. Such patients include those with moderate to severe renal impairment, hypothyroidism, a family history of muscle disorders, and patients with alcohol dependence. This medication contains lactose, so patients with lactose intolerance should not take it. Before taking this medication, regular liver function tests and muscle-related tests should be done, especially in patients who drink heavily or have a history of liver disease. If symptoms such as muscle pain, weakness, cramps, fatigue, or fever appear during treatment, inform a doctor immediately, and if necessary, blood tests should be performed to check for muscle damage. This medication may increase blood concentration when taken with specific other drugs, raising the risk of muscle damage, so if you are taking other medications, inform your doctor or pharmacist. Women of childbearing potential must use appropriate contraception when taking this medication, and if pregnancy is confirmed, they should discontinue use immediately. In case of overdose, there is no specific antidote available; therefore, treatment based on symptoms and regular monitoring of liver function and muscle enzyme levels are necessary. This medication can rarely cause serious skin reactions or liver damage; thus, if any unusual rash develops or jaundice symptoms appear, discontinue use immediately and consult a healthcare professional. Caution should also be taken due to the possibility of dizziness while driving or operating machinery. It is important to monitor liver and muscle function through regular health checks and blood tests during the course of this medication.
Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, respiratory distress, diarrhea, oculobulbar weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), drug eruption resembling pityriasis rosea, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, dysesthesia, chest discomfort, anorexia, abdominal distension, abnormal liver function tests, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air and moisture ingress. The storage temperature should be kept between 1 and 30 degrees Celsius at room temperature. Storing it this way will help maintain its effectiveness for a longer period.
Yellow round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Kips Biopharma Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.